hLL1

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hLL1, covering 2021-08-16 to 2021-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of hLL1 in Multiple Myeloma [Phase 1, Phase 2]